SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali
Issaka Sagara, John Woodford, Alassane Dicko, Amatigue Zeguime, M’Bouye Doucoure, Jennifer Kwan, Irfan Zaidi, Justin Doritchamou, Maryonne Snow-Smith, Nada Alani, Jonathan Renn, Ivan Kosik, Jaroslav Holly, Jonathan Yewdell, Dominic Esposito, Kaitlyn Sadtler, Patrick Duffy
doi: https://doi.org/10.1101/2021.03.08.21252784
Issaka Sagara
1MRTC/USTTB: oversight, planning, data review
John Woodford
2LMIV/NIAID/NIH: planning, data review, drafting
Alassane Dicko
1MRTC/USTTB: oversight, planning, data review
Amatigue Zeguime
3MRTC/USTTB: Mali lab activities
M’Bouye Doucoure
3MRTC/USTTB: Mali lab activities
Jennifer Kwan
4LCIM/NIAID/NIH: planning, data review
Irfan Zaidi
5LMIV/NIAID/NIH: planning, LMIV lab activities, data review
Justin Doritchamou
6LMIV/NIAID/NIH: LMIV lab activities, data review
Maryonne Snow-Smith
7LMIV/NIAID/NIH: LMIV lab activities
Nada Alani
7LMIV/NIAID/NIH: LMIV lab activities
Jonathan Renn
8LMIV/NIAID/NIH: NCP antigen production
Ivan Kosik
9LVD/NIAID/NIH: pseudovirus neutralization assay
Jaroslav Holly
10LVD/NIAID/NIH: BHK21-ACE2 expressing cell line production
Jonathan Yewdell
11LVD/NIAID/NIH: oversight pseudovirus neutralization assay
Dominic Esposito
12FNLCR/NIH: assay antigen production
Kaitlyn Sadtler
13NIBIB/NIH: advice, data review
Patrick Duffy
14LMIV/NIAID/NIH: funding, oversight, planning, data review
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The data that support the findings of this study are available in the manuscript
Posted March 12, 2021.
SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali
Issaka Sagara, John Woodford, Alassane Dicko, Amatigue Zeguime, M’Bouye Doucoure, Jennifer Kwan, Irfan Zaidi, Justin Doritchamou, Maryonne Snow-Smith, Nada Alani, Jonathan Renn, Ivan Kosik, Jaroslav Holly, Jonathan Yewdell, Dominic Esposito, Kaitlyn Sadtler, Patrick Duffy
medRxiv 2021.03.08.21252784; doi: https://doi.org/10.1101/2021.03.08.21252784
SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali
Issaka Sagara, John Woodford, Alassane Dicko, Amatigue Zeguime, M’Bouye Doucoure, Jennifer Kwan, Irfan Zaidi, Justin Doritchamou, Maryonne Snow-Smith, Nada Alani, Jonathan Renn, Ivan Kosik, Jaroslav Holly, Jonathan Yewdell, Dominic Esposito, Kaitlyn Sadtler, Patrick Duffy
medRxiv 2021.03.08.21252784; doi: https://doi.org/10.1101/2021.03.08.21252784
Subject Area
Subject Areas
- Addiction Medicine (331)
- Allergy and Immunology (655)
- Anesthesia (175)
- Cardiovascular Medicine (2548)
- Dermatology (214)
- Emergency Medicine (387)
- Epidemiology (12030)
- Forensic Medicine (10)
- Gastroenterology (724)
- Genetic and Genomic Medicine (3949)
- Geriatric Medicine (371)
- Health Economics (661)
- Health Informatics (2551)
- Health Policy (983)
- Hematology (354)
- HIV/AIDS (816)
- Medical Education (391)
- Medical Ethics (106)
- Nephrology (420)
- Neurology (3711)
- Nursing (205)
- Nutrition (553)
- Oncology (1929)
- Ophthalmology (560)
- Orthopedics (231)
- Otolaryngology (299)
- Pain Medicine (245)
- Palliative Medicine (71)
- Pathology (467)
- Pediatrics (1081)
- Primary Care Research (440)
- Public and Global Health (6379)
- Radiology and Imaging (1346)
- Respiratory Medicine (851)
- Rheumatology (389)
- Sports Medicine (336)
- Surgery (427)
- Toxicology (51)
- Transplantation (184)
- Urology (159)